cloudfront

Report Detail

Pharma & Healthcare Global Antibacterial Drug Resistance Market Insights, Forecast to 2025

  • RnM2359536
  • |
  • 17 April, 2019
  • |
  • Global
  • |
  • 148 pages
  • |
  • QYResearch
  • |
  • Pharma & Healthcare

Global Antibacterial Drug Resistance Market Insights, Forecast to 2025

Table of Contents

    1 Study Coverage

    • 1.1 Antibacterial Drug Resistance Product
    • 1.2 Market Segments
    • 1.3 Key Manufacturers Covered
    • 1.4 Market by Type
      • 1.4.1 Global Antibacterial Drug Resistance Market Size Growth Rate by Product
      • 1.4.2 Telavancin (Vibativ)
      • 1.4.3 Ceftaroline Fosamil (Teflaro/ Zinforo)
      • 1.4.4 Fidaxomicin (Dificid / Dificlir)
      • 1.4.5 Ceftobiprole Medocaril (Zevtera/ Zeftera/ Mabelio)
      • 1.4.6 Dalbavancin (Dalvance/ Xydalba)
      • 1.4.7 Tedizolid Phosphate (Sivextro)
      • 1.4.8 Oritavancin (Orbactiv/ Nuvocid)
      • 1.4.9 Ceftolozane-Tazobactam (Zerbaxa)
      • 1.4.10 Ceftazidime-Avibactam (Avycaz/ Zavicefta)
      • 1.4.11 PHASE III DRUGS
    • 1.5 Market by End User
      • 1.5.1 Global Antibacterial Drug Resistance Market Size Growth Rate by End User
      • 1.5.2 Gram-Positive
      • 1.5.3 Gram-Negative
    • 1.6 Study Objectives
    • 1.7 Years Considered

    2 Executive Summary

    • 2.1 Global Antibacterial Drug Resistance Market Size
      • 2.1.1 Global Antibacterial Drug Resistance Revenue 2014-2025
      • 2.1.2 Global Antibacterial Drug Resistance Sales 2014-2025
    • 2.2 Antibacterial Drug Resistance Growth Rate by Regions
      • 2.2.1 Global Antibacterial Drug Resistance Sales by Regions
      • 2.2.2 Global Antibacterial Drug Resistance Revenue by Regions

    3 Breakdown Data by Manufacturers

    • 3.1 Antibacterial Drug Resistance Sales by Manufacturers
      • 3.1.1 Antibacterial Drug Resistance Sales by Manufacturers
      • 3.1.2 Antibacterial Drug Resistance Sales Market Share by Manufacturers
      • 3.1.3 Global Antibacterial Drug Resistance Market Concentration Ratio (CR5 and HHI)
    • 3.2 Antibacterial Drug Resistance Revenue by Manufacturers
      • 3.2.1 Antibacterial Drug Resistance Revenue by Manufacturers (2014-2019)
      • 3.2.2 Antibacterial Drug Resistance Revenue Share by Manufacturers (2014-2019)
    • 3.3 Antibacterial Drug Resistance Price by Manufacturers
    • 3.4 Antibacterial Drug Resistance Manufacturing Base Distribution, Product Types
      • 3.4.1 Antibacterial Drug Resistance Manufacturers Manufacturing Base Distribution, Headquarters
      • 3.4.2 Manufacturers Antibacterial Drug Resistance Product Type
      • 3.4.3 Date of International Manufacturers Enter into Antibacterial Drug Resistance Market
    • 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

    4 Breakdown Data by Product

    • 4.1 Global Antibacterial Drug Resistance Sales by Product
    • 4.2 Global Antibacterial Drug Resistance Revenue by Product
    • 4.3 Antibacterial Drug Resistance Price by Product

    5 Breakdown Data by End User

    • 5.1 Overview
    • 5.2 Global Antibacterial Drug Resistance Breakdown Data by End User

    6 North America

    • 6.1 North America Antibacterial Drug Resistance by Countries
      • 6.1.1 North America Antibacterial Drug Resistance Sales by Countries
      • 6.1.2 North America Antibacterial Drug Resistance Revenue by Countries
      • 6.1.3 United States
      • 6.1.4 Canada
      • 6.1.5 Mexico
    • 6.2 North America Antibacterial Drug Resistance by Product
    • 6.3 North America Antibacterial Drug Resistance by End User

    7 Europe

    • 7.1 Europe Antibacterial Drug Resistance by Countries
      • 7.1.1 Europe Antibacterial Drug Resistance Sales by Countries
      • 7.1.2 Europe Antibacterial Drug Resistance Revenue by Countries
      • 7.1.3 Germany
      • 7.1.4 France
      • 7.1.5 UK
      • 7.1.6 Italy
      • 7.1.7 Russia
    • 7.2 Europe Antibacterial Drug Resistance by Product
    • 7.3 Europe Antibacterial Drug Resistance by End User

    8 Asia Pacific

    • 8.1 Asia Pacific Antibacterial Drug Resistance by Countries
      • 8.1.1 Asia Pacific Antibacterial Drug Resistance Sales by Countries
      • 8.1.2 Asia Pacific Antibacterial Drug Resistance Revenue by Countries
      • 8.1.3 China
      • 8.1.4 Japan
      • 8.1.5 Korea
      • 8.1.6 India
      • 8.1.7 Australia
      • 8.1.8 Indonesia
      • 8.1.9 Malaysia
      • 8.1.10 Philippines
      • 8.1.11 Thailand
      • 8.1.12 Vietnam
      • 8.1.13 Singapore
    • 8.2 Asia Pacific Antibacterial Drug Resistance by Product
    • 8.3 Asia Pacific Antibacterial Drug Resistance by End User

    9 Central & South America

    • 9.1 Central & South America Antibacterial Drug Resistance by Countries
      • 9.1.1 Central & South America Antibacterial Drug Resistance Sales by Countries
      • 9.1.2 Central & South America Antibacterial Drug Resistance Revenue by Countries
      • 9.1.3 Brazil
    • 9.2 Central & South America Antibacterial Drug Resistance by Product
    • 9.3 Central & South America Antibacterial Drug Resistance by End User

    10 Middle East and Africa

    • 10.1 Middle East and Africa Antibacterial Drug Resistance by Countries
      • 10.1.1 Middle East and Africa Antibacterial Drug Resistance Sales by Countries
      • 10.1.2 Middle East and Africa Antibacterial Drug Resistance Revenue by Countries
      • 10.1.3 GCC Countries
      • 10.1.4 Turkey
      • 10.1.5 Egypt
      • 10.1.6 South Africa
    • 10.2 Middle East and Africa Antibacterial Drug Resistance by Product
    • 10.3 Middle East and Africa Antibacterial Drug Resistance by End User

    11 Company Profiles

    • 11.1 AAIPharma Services
      • 11.1.1 AAIPharma Services Company Details
      • 11.1.2 Company Business Overview
      • 11.1.3 AAIPharma Services Antibacterial Drug Resistance Sales, Revenue and Gross Margin (2014-2019)
      • 11.1.4 AAIPharma Services Antibacterial Drug Resistance Products Offered
      • 11.1.5 AAIPharma Services Recent Development
    • 11.2 ANTABIO
      • 11.2.1 ANTABIO Company Details
      • 11.2.2 Company Business Overview
      • 11.2.3 ANTABIO Antibacterial Drug Resistance Sales, Revenue and Gross Margin (2014-2019)
      • 11.2.4 ANTABIO Antibacterial Drug Resistance Products Offered
      • 11.2.5 ANTABIO Recent Development
    • 11.3 Abgentis
      • 11.3.1 Abgentis Company Details
      • 11.3.2 Company Business Overview
      • 11.3.3 Abgentis Antibacterial Drug Resistance Sales, Revenue and Gross Margin (2014-2019)
      • 11.3.4 Abgentis Antibacterial Drug Resistance Products Offered
      • 11.3.5 Abgentis Recent Development
    • 11.4 Abbott Laboratories
      • 11.4.1 Abbott Laboratories Company Details
      • 11.4.2 Company Business Overview
      • 11.4.3 Abbott Laboratories Antibacterial Drug Resistance Sales, Revenue and Gross Margin (2014-2019)
      • 11.4.4 Abbott Laboratories Antibacterial Drug Resistance Products Offered
      • 11.4.5 Abbott Laboratories Recent Development
    • 11.5 Absynth Biologics
      • 11.5.1 Absynth Biologics Company Details
      • 11.5.2 Company Business Overview
      • 11.5.3 Absynth Biologics Antibacterial Drug Resistance Sales, Revenue and Gross Margin (2014-2019)
      • 11.5.4 Absynth Biologics Antibacterial Drug Resistance Products Offered
      • 11.5.5 Absynth Biologics Recent Development
    • 11.6 Achaogen
      • 11.6.1 Achaogen Company Details
      • 11.6.2 Company Business Overview
      • 11.6.3 Achaogen Antibacterial Drug Resistance Sales, Revenue and Gross Margin (2014-2019)
      • 11.6.4 Achaogen Antibacterial Drug Resistance Products Offered
      • 11.6.5 Achaogen Recent Development
    • 11.7 Acino Holdings
      • 11.7.1 Acino Holdings Company Details
      • 11.7.2 Company Business Overview
      • 11.7.3 Acino Holdings Antibacterial Drug Resistance Sales, Revenue and Gross Margin (2014-2019)
      • 11.7.4 Acino Holdings Antibacterial Drug Resistance Products Offered
      • 11.7.5 Acino Holdings Recent Development
    • 11.8 Aventis Pharma
      • 11.8.1 Aventis Pharma Company Details
      • 11.8.2 Company Business Overview
      • 11.8.3 Aventis Pharma Antibacterial Drug Resistance Sales, Revenue and Gross Margin (2014-2019)
      • 11.8.4 Aventis Pharma Antibacterial Drug Resistance Products Offered
      • 11.8.5 Aventis Pharma Recent Development
    • 11.9 Austell Laboratories
      • 11.9.1 Austell Laboratories Company Details
      • 11.9.2 Company Business Overview
      • 11.9.3 Austell Laboratories Antibacterial Drug Resistance Sales, Revenue and Gross Margin (2014-2019)
      • 11.9.4 Austell Laboratories Antibacterial Drug Resistance Products Offered
      • 11.9.5 Austell Laboratories Recent Development
    • 11.10 Assembly Biosciences
      • 11.10.1 Assembly Biosciences Company Details
      • 11.10.2 Company Business Overview
      • 11.10.3 Assembly Biosciences Antibacterial Drug Resistance Sales, Revenue and Gross Margin (2014-2019)
      • 11.10.4 Assembly Biosciences Antibacterial Drug Resistance Products Offered
      • 11.10.5 Assembly Biosciences Recent Development
    • 11.11 Arpida
    • 11.12 Demuris
    • 11.13 Evolva Holding
    • 11.14 ContraFect
    • 11.15 Cerexa
    • 11.16 GSK
    • 11.17 InterMune
    • 11.18 Isis Pharmaceuticals
    • 11.19 Lyndra
    • 11.20 Microbecide
    • 11.21 Morphochem
    • 11.22 Nabriva Therapeutics
    • 11.23 NanoSafe Coatings
    • 11.24 Novexel
    • 11.25 Osel
    • 11.26 PENDOPHARM
    • 11.27 Pfizer
    • 11.28 VenatoRx Pharmaceuticals

    12 Future Forecast

    • 12.1 Antibacterial Drug Resistance Market Forecast by Regions
      • 12.1.1 Global Antibacterial Drug Resistance Sales Forecast by Regions 2019-2025
      • 12.1.2 Global Antibacterial Drug Resistance Revenue Forecast by Regions 2019-2025
    • 12.2 Antibacterial Drug Resistance Market Forecast by Product
      • 12.2.1 Global Antibacterial Drug Resistance Sales Forecast by Product 2019-2025
      • 12.2.2 Global Antibacterial Drug Resistance Revenue Forecast by Product 2019-2025
    • 12.3 Antibacterial Drug Resistance Market Forecast by End User
    • 12.4 North America Antibacterial Drug Resistance Forecast
    • 12.5 Europe Antibacterial Drug Resistance Forecast
    • 12.6 Asia Pacific Antibacterial Drug Resistance Forecast
    • 12.7 Central & South America Antibacterial Drug Resistance Forecast
    • 12.8 Middle East and Africa Antibacterial Drug Resistance Forecast

    13 Market Opportunities, Challenges, Risks and Influences Factors Analysis

    • 13.1 Market Opportunities and Drivers
    • 13.2 Market Challenges
    • 13.3 Market Risks/Restraints
    • 13.4 Macroscopic Indicators

    14 Value Chain and Sales Channels Analysis

    • 14.1 Value Chain Analysis
    • 14.2 Antibacterial Drug Resistance Customers
    • 14.3 Sales Channels Analysis
      • 14.3.1 Sales Channels
      • 14.3.2 Distributors

    15 Research Findings and Conclusion

      16 Appendix

      • 16.1 Research Methodology
        • 16.1.1 Methodology/Research Approach
        • 16.1.2 Data Source
      • 16.2 Author Details

      The global Antibacterial Drug Resistance market is valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. The objectives of this study are to define, segment, and project the size of the Antibacterial Drug Resistance market based on company, product type, end user and key regions.

      This report studies the global market size of Antibacterial Drug Resistance in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Antibacterial Drug Resistance in these regions.
      This research report categorizes the global Antibacterial Drug Resistance market by top players/brands, region, type and end user. This report also studies the global Antibacterial Drug Resistance market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.

      The following manufacturers are covered in this report, with sales, revenue, market share for each company:
      AAIPharma Services
      ANTABIO
      Abgentis
      Abbott Laboratories
      Absynth Biologics
      Achaogen
      Acino Holdings
      Aventis Pharma
      Austell Laboratories
      Assembly Biosciences
      Arpida
      Demuris
      Evolva Holding
      ContraFect
      Cerexa
      GSK
      InterMune
      Isis Pharmaceuticals
      Lyndra
      Microbecide
      Morphochem
      Nabriva Therapeutics
      NanoSafe Coatings
      Novexel
      Osel
      PENDOPHARM
      Pfizer
      VenatoRx Pharmaceuticals

      Market size by Product
      Telavancin (Vibativ)
      Ceftaroline Fosamil (Teflaro/ Zinforo)
      Fidaxomicin (Dificid / Dificlir)
      Ceftobiprole Medocaril (Zevtera/ Zeftera/ Mabelio)
      Dalbavancin (Dalvance/ Xydalba)
      Tedizolid Phosphate (Sivextro)
      Oritavancin (Orbactiv/ Nuvocid)
      Ceftolozane-Tazobactam (Zerbaxa)
      Ceftazidime-Avibactam (Avycaz/ Zavicefta)
      PHASE III DRUGS
      Market size by End User
      Gram-Positive
      Gram-Negative

      Market size by Region
      North America
      United States
      Canada
      Mexico
      Asia-Pacific
      China
      India
      Japan
      South Korea
      Australia
      Indonesia
      Singapore
      Malaysia
      Philippines
      Thailand
      Vietnam
      Europe
      Germany
      France
      UK
      Italy
      Spain
      Russia
      Central & South America
      Brazil
      Rest of Central & South America
      Middle East & Africa
      GCC Countries
      Turkey
      Egypt
      South Africa

      The study objectives of this report are:
      To study and analyze the global Antibacterial Drug Resistance market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
      To understand the structure of Antibacterial Drug Resistance market by identifying its various subsegments.
      To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
      Focuses on the key global Antibacterial Drug Resistance companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
      To project the value and sales volume of Antibacterial Drug Resistance submarkets, with respect to key regions.
      To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

      In this study, the years considered to estimate the market size of Antibacterial Drug Resistance are as follows:
      History Year: 2014-2018
      Base Year: 2018
      Estimated Year: 2019
      Forecast Year 2019 to 2025

      This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Antibacterial Drug Resistance market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

      For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.


      Summary:
      Get latest Market Research Reports on Antibacterial Drug Resistance . Industry analysis & Market Report on Antibacterial Drug Resistance is a syndicated market report, published as Global Antibacterial Drug Resistance Market Insights, Forecast to 2025. It is complete Research Study and Industry Analysis of Antibacterial Drug Resistance market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.


      REPORT YOU MIGHT BE INTERESTED

      Purchase this Report

      $3,900.00
      $5,850.00
      $7,800.00
      2,618.85
      3,928.28
      5,237.70
      3,588.78
      5,383.17
      7,177.56
      472,446.00
      708,669.00
      944,892.00
      258,622.26
      387,933.39
      517,244.52
      Credit card Logo

      Related Reports


      Reason to Buy

      Request for Sample of this report